Application of CTCF snare protein in preparation of anti-uveal melanoma medicine

A technology for melanoma and uvea, which is applied in the field of application of CTCF trap protein in the preparation of anti-uveal melanoma drugs, can solve the problems of unclear curative effect and mechanism of action of uveal melanoma, reduce the enucleation rate, improve Effectiveness of treatment, effect of improving visual prognosis

Active Publication Date: 2017-07-04
SHANGHAI NINTH PEOPLES HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

CTCF trap protein has been confirmed to regulate gene expression by changing the chromosome conformation of cells, but its app

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of CTCF snare protein in preparation of anti-uveal melanoma medicine
  • Application of CTCF snare protein in preparation of anti-uveal melanoma medicine
  • Application of CTCF snare protein in preparation of anti-uveal melanoma medicine

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0019] Example 1

[0020] Cell Proliferation Experiment (CCK8)

[0021] Experimental material: CCK8 purchased from Japan Tongren Chemical

[0022] Construct CTCF trap protein stably expressing UM and normal cell lines, add the lentivirus containing CTCF trap protein to UM cells and normal cells, 37°C, 5% CO 2 Cultivate for 48 hours, and screen with puromycin at a final concentration of 8ug / ml for 4 weeks after passage. After Realtime PCR verifies the expression of CTCF trap protein, inoculate stable transgenic cells and tumor cells in a 96-well plate, 5000 cells per well, 100ul culture medium, 37℃, 5% CO 2 Cultivate, add 10ul CCK8 at 0h, 24h, 48h, 72h respectively, continue to incubate at 37℃ for 4h, and measure the absorbance value on the machine figure 2 . From figure 2 It can be concluded that the trap CTCF protein can significantly inhibit the proliferation of uveal melanoma, and has no effect on the ability of normal cell proliferation.

Example Embodiment

[0023] Example 2

[0024] Experiment name: Transwell cell migration experiment

[0025] Experimental materials: Transwell chamber was purchased from Millipore (Millipore, USA); Six-well plate was purchased from ThermoFisher (Thermo Fisher, USA); Crystal Violet was purchased from Shenggong Company (Sanggong China).

[0026] Experimental procedure: Use 8μm 24-well plate Transwell chamber. Add 900 μl of 10% FBS DMEM culture medium to each well of the 24-well plate, hang the chambers in 24 wells, and inoculate 10,000 cells in 200 μl of 2% FBS DMEM culture medium for each chamber. After culturing for 2 to 3 days, aspirate the culture fluid in the wells and chambers, and carefully wash once with PBS. Add crystal violet for staining for 30 minutes, and carefully wash once with PBS. Wipe all the cells tested in the chamber. The cells outside the chamber were photographed and observed. Use 33% acetic acid solution to completely dissolve the crystal violet, measure the OD value with a mic...

Example Embodiment

[0027] Example 3

[0028] Subcutaneous tumor formation experiment in nude mice

[0029] Experimental materials: 4-week-old male nude mice (provided by the SPF animal room of the Ninth People's Hospital, Shanghai Jiaotong University School of Medicine)

[0030] Experimental procedure: UM cells and stable transgenic cells were counted and centrifuged at 800 rpm for 5 minutes, and each nude mouse was injected subcutaneously 3*10 6 After culturing the cells for one week, start measuring the size of the subcutaneous tumors in the nude mice, and measuring twice a week for mapping. After 28 days, the nude mice were sacrificed, and the tumors were taken out and weighed. Figure 4 ,From Figure 4 It can be concluded that the trap CTCF protein can significantly inhibit the tumorigenesis ability of uveal melanoma in vivo.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of anticancer medicines and particularly discloses an application of a CTCF snare protein in preparation of an anti-uveal melanoma medicine. The CTCF snare protein is an artificially expressed recombinant protein, wherein N-terminal and C-terminal functional zones of a wild-type CTCF are removed, while a zinc finger structure ZF is remained and DNA methylase Sss1 is added. A researching result proves that by transferring the CTCF snare in an UM cell, growth and metastasis of the uveal melanoma can be effectively inhibited. The CTCF snare protein provides a new target point and a therapy medicine for clinical treatment of the uveal melanoma, improves therapy validity, reduces rate of eyeball removal, and improves visional prognosis of patients.

Description

technical field [0001] The invention belongs to the field of antitumor drugs, and in particular relates to the application of a CTCF trap protein in the preparation of anti-uveal melanoma drugs. Background technique [0002] Uveal melanoma (Uveal melanoma, UM) is the most common primary intraocular malignant tumor in adults. UM usually occurs unilaterally and unifocally, but rare cases of bilateral or multifocal tumors within the same eye occur. UM has a high degree of malignancy, which can not only lead to vision loss, but also easily metastasize to the blood, mainly to the liver, which seriously threatens the life of the patient. Due to the lack of effective early diagnosis and treatment methods, UM patients often die within one year after diagnosis. Even if the affected eye is enucleated without definite distant metastasis, the 5-year mortality rate is still as high as 17%-53%. In recent years, the incidence of melanoma has shown an increasing trend, with an annual gro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K38/17A61P35/00
CPCA61K38/1709
Inventor 张赫范先群文旭洋王茜李芳葛盛芳贾仁兵
Owner SHANGHAI NINTH PEOPLES HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap